General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The market for CSF management devices includes adjustable and fixed pressure shunts as well as ventricular and lumbar external drainage systems. The market will experience mid-single digit growth over the forecast period, driven primarily by growth in the adjustable pressure shunt market segment. This market segment is also the largest, followed by ventricular drainage systems, fixed pressure shunts and then lumbar drainage systems.
Adjustable pressure shunts are expected to remain the largest segment and are expected to maintain the highest growth. Fixed pressure shunts will remain the second smallest segment and will decline over the forecast period. A declining market will also be seen for the smallest segment, the lumbar drainage system. The ventricular drainage system segment will stay fairly stable with a slight decrease in market value due to competitive pricing.
There is room in this market for substantial innovation as many of the technologies still experience significant complications and novel medical devices to overcome these issues could drive up prices and increase the market value.
'
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIII
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
PRODUCT ASSESSMENT 55
4.1 PRODUCT PORTFOLIOS 55
4.1.1 Cerebrospinal Fluid Management 55
4.1.1.1 Introduction 55
4.1.1.2 Product Matrix for CFS Management market: Core Companies (1 of 2) 58
4.1.1.3 Product Matrix for CFS Management market: Core Companies (2 of 2) 59
4.2 REGULATORY ISSUES AND RECALLS 60
4.2.1 Cerebrospinal Fluid Management 60
4.3 CLINICAL TRIALS 66
4.3.1 Cerebrospinal Fluid Management 66
CEREBROSPINAL FLUID MANAGEMENT MARKET 68
5.1 INTRODUCTION 68
5.2 MARKET OVERVIEW 70
5.3 MARKET ANALYSIS AND FORECAST 74
5.3.1 Total Cerebrospinal Fluid Shunt Market 74
5.3.1.1 Pressure Adjustable Cerebrospinal Fluid Shunt Market 77
5.3.1.2 Fixed Pressure Cerebrospinal Fluid Shunt Market 84
5.3.2 Total Cerebrospinal Fluid External Drainage System Market 91
5.3.2.1 Ventricular Drainage System Market 93
5.3.2.2 Lumbar Drainage System Market 100
5.4 DRIVERS AND LIMITERS 107
5.4.1 Market Drivers 107
5.4.2 Market Limiters 108
5.5 COMPETITIVE MARKET SHARE ANALYSIS 111
ABBREVIATIONS 116
APPENDIX: COMPANY PRESS RELEASES 119
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 5 1: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023 72
Chart 5 2: Cerebrospinal Fluid Management Market Breakdown, Europe, 2016 73
Chart 5 3: Cerebrospinal Fluid Management Market Breakdown, Europe, 2023 73
Chart 5 4: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023 76
Chart 5 5: Pressure Adjustable Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023 78
Chart 5 6: Fixed Pressure Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023 85
Chart 5 7: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023 92
Chart 5 8: Ventricular Drainage System Market, Europe, 2013 – 2023 94
Chart 5 9: Lumbar Drainage System Market, Europe, 2013 – 2023 101
Chart 5 10: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2016 115
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Shunt Types 56
Figure 4 2: Class 2 Device Recall: VentriClear II Ventricular Drainage Catheter Set, Cook Inc. 60
Figure 4 3: Class 2 Device Recall: Aesculap Miethke Shunt System 60
Figure 4 4: Class 2 Device Recall: Aesculap Miethke Shunt System, miniNAV Valve 60
Figure 4 5: Class 2 Device Recall: Codman 61
Figure 4 6: Class 2 Device Recall: Codman Cetras 62
Figure 4 7: Class 2 Device Recall: Medtronic Duet External Drainage and Monitoring System 63
Figure 4 8: Class 2 Device Recall: Aesculap Inc. (AIC) Miethke Ventricular Catheter with Deflector/Miethke Shunt System 63
Figure 4 9: Class 2 Device Recall: Aesculap 63
Figure 4 10: Class 2 Device Recall: Integra Cranial Access Kit 64
Figure 4 11: Class 2 Device Recall: Integra Cranial Access Kit 64
Figure 4 12: Class 2 Device Recall: CSFUnitized Shunt, Medtronic 64
Figure 4 13: Class 2 Device Recall: Aesculap(R) Miethke Shunt System 65
Figure 4 14: Class 2 Device Recall: Pudenz Flushing Valve 65
Figure 4 15: CSF Management: Strata Programmable CSF Shunt Valve Study 66
Figure 4 16: CSF Management: Cerebrospinal Fluid (CSF) Drainage Study 66
Figure 4 17: CSF Management: Lumbar Drainage in Subarachnoid Haemorrhage (LUMAS) 67
Figure 5 1: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023 (€M) 71
Figure 5 2: Cerebrospinal Fluid Management Market by Segment, Europe, 2013 – 2023 (US$M) 71
Figure 5 3: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023 (€M) 75
Figure 5 4: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2013 – 2023 (US$M) 75
Figure 5 5: Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€ and US$) 78
Figure 5 6: Units Sold by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 79
Figure 5 7: Average Selling Price by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€) 80
Figure 5 8: Average Selling Price by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$) 81
Figure 5 9: Market Value by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€M) 82
Figure 5 10: Market Value by Country, Total Pressure Adjustable Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$M) 83
Figure 5 11: Fixed Pressure Cerebrospinal Fluid Shunt Market, U.S., 2013 – 2023 (€ and US$) 85
Figure 5 12: Units Sold by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 86
Figure 5 13: Average Selling Price by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€) 87
Figure 5 14: Average Selling Price by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$) 88
Figure 5 15: Market Value by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (€M) 89
Figure 5 16: Market Value by Country, Total Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2013 – 2023 (US$M) 90
Figure 5 17: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023 (€M) 91
Figure 5 18: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2013 – 2023 (US$M) 92
Figure 5 19: Ventricular Drainage System Market, Europe, 2013 – 2023 (€ and US$) 93
Figure 5 20: Units Sold by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 95
Figure 5 21: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (€) 96
Figure 5 22: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (US$) 97
Figure 5 23: Market Value by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (€M) 98
Figure 5 24: Market Value by Country, Ventricular Drainage System Market, Europe, 2013 – 2023 (US$M) 99
Figure 5 25: Lumbar Drainage System Market, Europe, 2013 – 2023 (€ and US$) 100
Figure 5 26: Units Sold by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 102
Figure 5 27: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (€) 103
Figure 5 28: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (US$) 104
Figure 5 29: Market Value by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (€M) 105
Figure 5 30: Market Value by Country, Lumbar Drainage System Market, Europe, 2013 – 2023 (US$M) 106
Figure 5 31: Drivers and Limiters, Cerebrospinal Fluid Management Market, Europe, 2016 110
Figure 5 32: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2016 115
Figure 7 1: Press Release Summary 119
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
